Literature DB >> 18779597

SWOG S0023: what meets the eye may be only half the truth.

Manisha Bhutani, Ashutosh K Pathak, Li Mao.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18779597     DOI： 10.1200/JCO.2008.18.4218

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer.

Authors:  Ritsuko Komaki; Pamela K Allen; Xiong Wei; George R Blumenschein; Ximing Tang; J Jack Lee; James W Welsh; Ignacio I Wistuba; Diane D Liu; Waun Ki Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-06-01       Impact factor: 7.038

2.  EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.

Authors:  Song Ee Park; Jae Myoung Noh; You Jin Kim; Han Sang Lee; Jang Ho Cho; Sung Won Lim; Yong Chan Ahn; Hongryull Pyo; Yoon-La Choi; Joungho Han; Jong-Mu Sun; Se Hoon Lee; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
Journal:  Cancer Res Treat       Date:  2018-06-18       Impact factor: 4.679
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.